DNA Capital

Luiz Noronha is a partner at DNA Capital working on venture capital investments, with more than fifteen years of experience investing in early-stage companies. Before DNA Capital, he invested in technology companies at DGF Investimentos and earlier worked on the investment team of Ficus Investimentos, where he served as a board member and CFO of a portfolio company. He earned a Bachelor of Science in Mechanical Engineering from Universidade de São Paulo.

Mario Sergio Ribeiro is a partner at DNA Capital focused on private equity. Before DNA Capital, he worked in asset management at Banco Bozano, was Vice-President at One Health, and Sales Manager at Grupo Amil. He holds an Economics degree from Instituto Brasileiro de Mercado de Capitais and an MBA in Business Administration and Marketing from Fundação Instituto de Administração, with additional executive education at INSEAD and Singularity University.

Partha Mishra is a partner at DNA Capital focused on venture capital investments. He previously served for 12 years as president and CEO of Optum Global Solutions, the healthcare technology and services unit of UnitedHealth Group, and earlier held healthcare leadership roles at Cognizant and Capgemini. He holds a bachelor's degree in electrical engineering technology from VSS University of Technology and an MBA from the Xavier Institute of Management in India.

Pedro Bueno is a partner at DNA Capital and serves as CEO of the company formed by the merger of diagnostics firm DASA and hospital chain Rede Ímpar, sitting on the boards of both. He started in investment banking at BTG Pactual working on M&A transactions, then joined Amil in 2012 and took part in its sale to UnitedHealth Group before becoming CEO of DASA. He holds a B.A. in Economics from Pontifícia Universidade Católica do Rio de Janeiro.

Thayan Hartmann is a partner on the private equity team at DNA Capital. Before joining the firm, he was an associate in the private equity team at Angra Partners. He is a CFA Charterholder, a Securities Portfolio Manager authorized by the CVM, and holds the CGA designation from ANBIMA, along with a degree in Aerospace Engineering from the University of São Paulo.

Camila Guimarães joined DNA Capital in 2019 as Chief Legal Officer, overseeing Compliance, Risk, AML, and ESG. She previously served as Legal Counsel at Farallon Capital Management's São Paulo office and worked as a lawyer at Stocche Forbes Advogados. She holds a double bachelor's degree in Business Administration and Law from Fundação Getulio Vargas (FGV).

Daniel Studart is a private equity analyst at DNA Capital, based in São Paulo. He previously worked on the private equity team at Pátria Investimentos, where he covered the food and beverage sector before moving to the M&A team of a food retail portfolio company. He holds a degree in Civil-Aeronautical Engineering from the Instituto Tecnológico de Aeronáutica (ITA).

Henrique Bandeira is an associate at DNA Capital working on venture capital investments. He previously spent over five years in M&A and strategic consulting at ADVISIA OC&C and Oliver Wyman, and worked two years at an educational NGO. He holds a bachelor's degree in Chemical Engineering from Universidade Federal do Rio Grande do Sul.

Julia Prado is a private equity associate at DNA Capital, based in São Paulo. She previously worked on the private equity team at Pátria Investimentos in the M&A team of Crop Care Holding, and earlier spent two years as a private equity analyst and three years as a wealth management analyst at Icatu Holding. She is a CFA Charterholder and holds a bachelor's degree in Industrial Engineering from Pontifícia Universidade Católica do Rio de Janeiro.

Lucas Cortez is a Vice President at DNA Capital working on venture capital investments. Before joining the firm, he spent five years as an analyst and associate at ADVISIA OC&C, working on projects across multiple sectors. He holds a bachelor's degree in Mechanical Engineering from Universidade Estadual de Campinas and the CGE certification from ANBIMA.

Luiz Felipe Costa is a partner at DNA Capital, focused on private equity and based in São Paulo. Before joining the firm, he was a founding partner at Stocche Forbes Advogados and a partner at Machado Meyer Advogados, with over 20 years of experience in law and cross-border M&A transactions. He holds a B.Sc. and an LLM in Law from Universidade de São Paulo.

Ricardo Lima is the CFO at DNA Capital. He previously spent five years as a controller at Viveo S.A., where he took part in more than 25 acquisitions and the company's 2021 IPO, and earlier held roles as CFO of oil and gas company Maxen, M&A manager at A Geradora, and investment professional at DGF Investimentos, Pulsar Invest, and GG Investimentos. He holds a degree in Business Administration from FGV-EAESP.